WallStreetZenWallStreetZen

NASDAQ: CLSD
Clearside Biomedical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CLSD

Based on 4 analysts offering 12 month price targets for Clearside Biomedical Inc

Min Forecast
$3.00+646.27%
Avg Forecast
$4.75+1,081.59%
Max Forecast
$6.00+1,392.54%

Should I buy or sell CLSD stock?

Based on 4 analysts offering ratings for Clearside Biomedical Inc.

Buy
Strong Buy
1 analysts 25%
Buy
1 analysts 25%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLSD stock forecasts and price targets.

CLSD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025‑07‑18
lockedlocked$00.00+00.00%2025‑07‑17
lockedlocked$00.00+00.00%2025‑05‑16
lockedlocked$00.00+00.00%2025‑03‑28

1 of 1

Forecast return on equity

Is CLSD forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is CLSD forecast to generate an efficient return on assets?

Company
-43.46%
Industry
47.5%
CLSD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLSD earnings per share forecast

What is CLSD's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.35
Avg 2 year Forecast
-$0.29
Avg 3 year Forecast
-$0.06

CLSD revenue forecast

What is CLSD's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$3.3M+127.68%
Avg 2 year Forecast
$6.0M+318.2%
Avg 3 year Forecast
$15.7M+995.54%
CLSD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLSD revenue growth forecast

How is CLSD forecast to perform vs Biotechnology companies and vs the US market?

Company
112.27%
Industry
79.33%
Market
10.78%
CLSD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLSD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLSD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLSD$0.40$4.75+1,081.59%Buy
MURA$1.80$6.00+233.33%Buy
MEIP$4.68N/AN/A
ANTX$1.15$2.00+73.91%Buy
RANI$0.55$7.33+1,235.70%Strong Buy
View Top Biotech Stocks

Clearside Biomedical Stock Forecast FAQ

Is Clearside Biomedical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CLSD) stock is to Buy CLSD stock.

Out of 4 analysts, 1 (25%) are recommending CLSD as a Strong Buy, 1 (25%) are recommending CLSD as a Buy, 2 (50%) are recommending CLSD as a Hold, 0 (0%) are recommending CLSD as a Sell, and 0 (0%) are recommending CLSD as a Strong Sell.

If you're new to stock investing, here's how to buy Clearside Biomedical stock.

What is CLSD's earnings growth forecast for 2025-2027?

(NASDAQ: CLSD) Clearside Biomedical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.

Clearside Biomedical's earnings in 2025 is -$30,811,000.On average, 4 Wall Street analysts forecast CLSD's earnings for 2025 to be -$26,809,445, with the lowest CLSD earnings forecast at -$32,637,585, and the highest CLSD earnings forecast at -$18,650,049. On average, 4 Wall Street analysts forecast CLSD's earnings for 2026 to be -$22,341,204, with the lowest CLSD earnings forecast at -$37,300,097, and the highest CLSD earnings forecast at -$777,085.

In 2027, CLSD is forecast to generate -$4,273,969 in earnings, with the lowest earnings forecast at -$7,770,854 and the highest earnings forecast at -$777,085.

What is CLSD's revenue growth forecast for 2025-2027?

(NASDAQ: CLSD) Clearside Biomedical's forecast annual revenue growth rate of 112.27% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.78%.

Clearside Biomedical's revenue in 2025 is $1,434,000.On average, 4 Wall Street analysts forecast CLSD's revenue for 2025 to be $253,718,370, with the lowest CLSD revenue forecast at $216,029,730, and the highest CLSD revenue forecast at $271,979,876. On average, 4 Wall Street analysts forecast CLSD's revenue for 2026 to be $466,018,090, with the lowest CLSD revenue forecast at $46,625,122, and the highest CLSD revenue forecast at $1,576,706,195.

In 2027, CLSD is forecast to generate $1,220,801,101 in revenue, with the lowest revenue forecast at $116,562,804 and the highest revenue forecast at $2,325,039,397.

What is CLSD's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CLSD) forecast ROA is -43.46%, which is lower than the forecast US Biotechnology industry average of 47.5%.

What is CLSD's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CLSD price target, the average CLSD price target is $4.75, with the highest CLSD stock price forecast at $6.00 and the lowest CLSD stock price forecast at $3.00.

On average, Wall Street analysts predict that Clearside Biomedical's share price could reach $4.75 by Jul 18, 2026. The average Clearside Biomedical stock price prediction forecasts a potential upside of 1,081.59% from the current CLSD share price of $0.40.

What is CLSD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CLSD) Clearside Biomedical's current Earnings Per Share (EPS) is -$0.41. On average, analysts forecast that CLSD's EPS will be -$0.35 for 2025, with the lowest EPS forecast at -$0.42, and the highest EPS forecast at -$0.24. On average, analysts forecast that CLSD's EPS will be -$0.29 for 2026, with the lowest EPS forecast at -$0.48, and the highest EPS forecast at -$0.01. In 2027, CLSD's EPS is forecast to hit -$0.06 (min: -$0.10, max: -$0.01).

What is CLSD's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CLSD) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.